Acute Porphyria Drug Database

N06BA04 - Methylphenidate
Propably not porphyrinogenic
PNP

Rationale
Not CYP-metabolised. No data pointing to CYP-induction. References consider it safe.
Chemical description
(To be edited, initial data ST OCT 04) Narcotic psychostimulant used in treatment of attention deficit hyperactivity (ADH). Metabolized by de-esterification to alphaphenylpiperidine acetic acid. No data pointing to CYP-induction. EPI-list: safe. South African list: use. Australian list: safe.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes N06B / N06BA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙